InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.13
(
1.07%
)
US TECH 100
18,724.40
(
2.06%
)
Dow Jones
40,861.71
(
0.31%
)
Brent Oil
70.61
(
0.12%
)
Bitcoin
57,933.61
(
1.03%
)
Post# of 64738
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Paulness

Send PM Follow Ignore
Followers 94
Posts 11282
Boards Moderated 0
Alias Born 11/02/2003

Paulness

Re: Chadman post# 17808

Thursday, 03/31/2005 1:15:20 PM

Thursday, March 31, 2005 1:15:20 PM

Post# of 64738
Yes Chadman very good NEWS
Dr. Yin Chen, CytoGenix' Vice President and Chief Scientific Officer, commented, "The introduction of CY403 into the preclinical product development phase within three months after target discovery and validation demonstrates the true value of our gene silencing technology. We have the capability to move very efficiently from discovery to product candidate in a matter of a few months
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up